DeutschNewstral
Article
bizjournals.com on 2018-07-09 14:45
Baltimore biotech targeting rare diseases raises $4 million
Related news
- Baltimore biopharma targeting eye diseases raises $5 millionbizjournals.com
- Baltimore biotech raises $4M to fuel trials for Covid vaccine, rare disease drugbizjournals.com
- Baltimore biotech WindMIL Therapeutics raises $32.5 millionbizjournals.com
- Baltimore biotech developing diabetes treatments raises $20.5Mbizjournals.com
- Baltimore biotech raises $1.6M to put toward wound healing solutionbizjournals.com
- Baltimore biotech Delfi Diagnostics raises $100 million funding roundbizjournals.com
- Montco firm targeting neurodegenerative diseases raises $1.6Mbizjournals.com
- BHow Biotech Is Targeting RNA to Cure Diseasesbarrons.com
- Malvern biotech firm targeting cancer raises $70.2Mbizjournals.com
- St. Louis biotech startup relocates to Baltimorebizjournals.com
- Baltimore biotech firm raising $111.5 millionbizjournals.com
- Former Sucampo CEO lands at Baltimore biotechbizjournals.com
- Malvern gene therapy company targeting heart diseases raises $17Mbizjournals.com
How Gene Editing Therapies Could Go Beyond Rare DiseasesForbes
Baltimore biotech firm launches kit for rapid DNA extractionthedailyrecord.com
Biotech company to manufacture Ebola treatment in Baltimorewkrg.com- California public company Pacific Biosciences acquires Baltimore biotechbizjournals.com
- Raleigh biotech targeting cancer raises $37M, plans to triple headcountbizjournals.com
- Targeting more childhood cancers, Peninsula biotech raises $130Mbizjournals.com